Programmed Cell Death Protein 1 (PD-1) and Programmed Cell Death Ligand 1 (PD-L1) Immunotherapy: A Promising Breakthrough in Cancer Therapeutics

The advent of immune checkpoint inhibitors has revolutionized cancer therapy by leveraging the body's immune system to combat malignancies effectively. Among these groundbreaking agents, programmed cell death protein 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors have emerged as...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Curēus (Palo Alto, CA) CA), 2023-09, Vol.15 (9), p.e44582-e44582
Hauptverfasser:	Abaza, Abdelrahman, Sid Idris, Faten, Anis Shaikh, Humna, Vahora, Ilma, Moparthi, Kiran Prasad, Al Rushaidi, Majdah T, Muddam, Meghana Reddy, Obajeun, Omobolanle A, Jaramillo, Arturo P, Khan, Safeera
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Apoptosis Bias Cancer Cell death Clinical outcomes Clinical trials Immune system Immunotherapy Ligands Medical research Oncology Pathology Proteins Therapeutics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!